Neogen Corp. (NEOG)
11.98
-1.04
(-7.96%)
USD |
NASDAQ |
Oct 06, 16:00
13.27
+1.30
(+10.81%)
After-Hours: 19:39
Neogen Cash from Operations (Quarterly) : 30.20M for May 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 30.20M |
| February 28, 2026 | 22.70M |
| November 30, 2025 | 19.44M |
| August 31, 2025 | 10.85M |
| May 31, 2025 | 14.52M |
| February 28, 2025 | 19.36M |
| November 30, 2024 | 40.25M |
| August 31, 2024 | -17.91M |
| May 31, 2024 | 26.65M |
| February 29, 2024 | -30.26M |
| November 30, 2023 | 15.32M |
| August 31, 2023 | 23.01M |
| May 31, 2023 | 90.97M |
| February 28, 2023 | -17.07M |
| November 30, 2022 | -18.73M |
| August 31, 2022 | -14.14M |
| May 31, 2022 | 20.39M |
| February 28, 2022 | 6.591M |
| November 30, 2021 | 17.85M |
| August 31, 2021 | 23.21M |
| May 31, 2021 | 21.97M |
| February 28, 2021 | 11.60M |
| November 30, 2020 | 22.39M |
| August 31, 2020 | 25.13M |
| May 31, 2020 | 25.63M |
| Date | Value |
|---|---|
| February 29, 2020 | 19.78M |
| November 30, 2019 | 16.75M |
| August 31, 2019 | 23.72M |
| May 31, 2019 | 20.88M |
| February 28, 2019 | 10.38M |
| November 30, 2018 | 16.50M |
| August 31, 2018 | 16.08M |
| May 31, 2018 | 22.56M |
| February 28, 2018 | 19.17M |
| November 30, 2017 | 8.736M |
| August 31, 2017 | 18.67M |
| May 31, 2017 | 15.09M |
| February 28, 2017 | 15.64M |
| November 30, 2016 | 9.273M |
| August 31, 2016 | 20.28M |
| May 31, 2016 | 7.319M |
| February 29, 2016 | 7.151M |
| November 30, 2015 | 14.26M |
| August 31, 2015 | 6.60M |
| May 31, 2015 | 10.32M |
| February 28, 2015 | 10.10M |
| November 30, 2014 | 12.94M |
| August 31, 2014 | 10.42M |
| May 31, 2014 | 4.506M |
| February 28, 2014 | 6.433M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 347.16M |
| QuidelOrtho Corp. | -110.60M |
| Aspira Women's Health, Inc. | -2.01M |
| VolitionRX Ltd. | -4.993M |
| Lucid Diagnostics, Inc. | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.00M |
| Cash from Financing (Quarterly) | -0.30M |
| Free Cash Flow | 31.90M |
| Free Cash Flow Per Share (Quarterly) | 0.1203 |
| Free Cash Flow to Equity (Quarterly) | 7.50M |
| Free Cash Flow to Firm (Quarterly) | 39.18M |
| Free Cash Flow Yield | 1.22% |